FDA clears Median Technologies’ lung nodule evaluation software
The US Food and Drug Administration (FDA) has cleared a lung cancer detection tool on Median Technologies’ eyonis, a suite …
Post
-
-
Medtronic ordered to pay $382m in anticompetitive surgical device lawsuit
A California court has ordered Medtronic pay surgical device rival Applied Medical almost $382m in damages after determining that the …
-
Sonorous receives FDA breakthrough designation for BosSTENT device
Sonorous Neurovascular has received breakthrough device designation from the US Food and Drug Administration (FDA) for its braided, self-expanding cerebral …
-
Abbott reports positive VERITAS study results for AFib
Abbott has reported positive early data from the VERITAS study, evaluating its investigational Amulet 360 left atrial appendage (LAA) occluder, …
-
FDA classifies J&J MedTech’s CEREPAK recall as Class I following patient death
The US Food and Drug Administration (FDA) has classified the recall of Johnson & Johnson (J&J) MedTech’s CEREPAK Detachable Coil …
-
University of Galway opens medtech prototype hub under Medtronic partnership
Ireland’s University of Galway has a launched a new medical device prototype hub, representing the latest milestone in its ongoing …
-
Wearables’ future in healthcare likely to hinge on actionable insights
The days of wearables collecting data and merely providing these insights back to users are numbered, with the inclusion of …
-
GE HealthCare and Diagnoly integrate AI solutions for foetal ultrasound
GE HealthCare has announced an AI-enabled foetal ultrasound collaboration with Diagnoly, a deeptech company known for prenatal screening. The agreement aims …
-
FDA grants clearance for Eyas Medical Imaging’s neonatal MRI system
The US Food and Drug Administration (FDA) has granted 510(k) clearance for Eyas Medical Imaging’s Ascent³ᵀ neonatal magnetic resonance imaging …
-
Biocomposites gains EU MDR certification for antibiotics carrier
Biocomposites’ STIMULAN bone infection management products have gained certification under the European Union’s Medical Device Regulation (EU MDR). The British medtech …
-
Boston Scientific’s shares tumble 18% despite strong FY25 growth
Despite reporting revenue of $20bn in its fiscal year 2025 (FY25) and strong growth in Q4 2025, Boston Scientific’s shares …
-
UK’s NICE greenlights Abbott’s CardioMEMS heart failure sensor
The UK’s National Institute for Health and Care Excellence (NICE) has recommended medtech giant Abbott’s heart failure sensor CardioMEMS. This means …
-
Jupiter Endovascular completes SPIRARE II trial enrolment for Vertex system
Jupiter Endovascular has completed patient enrolment in the SPIRARE II pivotal clinical trial of its Vertex pulmonary embolectomy (PE) system, …
-
Hologic’s Aptima assay secures FDA approval for HPV primary screening
Hologic has received the US Food and Drug Administration (FDA) approval for its Aptima HPV assay for use in clinician-collected …
-
J.P. Morgan Healthcare Conference 2026 Report
The J. P. Morgan Healthcare Conference 2026 (JPM 2026) offers an early view of investor sentiment in the healthcare industry …
